DMAG, a novel countermeasure for the treatment of thrombocytopenia
Abstract Background Thrombocytopenia is one of the most common hematological disease that can be life-threatening caused by bleeding complications. However, the treatment options for thrombocytopenia remain limited. Methods In this study, giemsa staining, phalloidin staining, immunofluorescence and...
Guardado en:
Autores principales: | Jing Lin, Jing Zeng, Sha Liu, Xin Shen, Nan Jiang, Yue-Song Wu, Hong Li, Long Wang, Jian-Ming Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/494bfa9258a94516a6707f5188aa45a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correction to: A Journey in Science: Immersion in the search for effective cancer immunotherapies
por: Steven A. Rosenberg
Publicado: (2021) -
ADSCs enhance VEGFR3-mediated lymphangiogenesis via METTL3-mediated VEGF-C m6A modification to improve wound healing of diabetic foot ulcers
por: Jie Zhou, et al.
Publicado: (2021) -
Predictive Value of the Platelet-to-Albumin Ratio (PAR) on the Risk of Death at Admission in Patients Suffering from Severe Fever with Thrombocytopenia Syndrome
por: Gui Y, et al.
Publicado: (2021) -
Editor'den [Editorial] 30. Yilimizi Kutluyoruz [We are celebrating the 30th Anniversary]
por: N. Leyla Acan, et al.
Publicado: (2006) -
The insulin centennial—100 years of milestones in biochemistry
por: Alan D. Attie, et al.
Publicado: (2021)